{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:47Z","timestamp":1786969667757,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Bulky tumors, defined as lesions exceeding 5 cm in maximum diameter, remain among the most challenging scenarios in radiation oncology. These tumors are often characterized by extensive hypoxia, radioresistance, and proximity to dose-limiting organs at risk, rendering conventional homogeneous-dose radiotherapy suboptimal. Lattice radiotherapy (LRT), a three-dimensional evolution of spatially fractionated radiation therapy (SFRT), offers a paradigm-shifting approach by delivering ablative doses to discrete high-dose vertices within the gross tumor volume while maintaining low peripheral doses. Since the first clinical application in 2014, the global experience has expanded to over 300 patients across lung, head and neck, gynecological, sarcoma, and other sites, demonstrating tumor volume reductions frequently exceeding 50% with minimal toxicity. Recent meta-analytic data from 187 patients confirm pooled 3-month complete and partial response rates of approximately 37% and 42%, respectively, with severe adverse events below 4%. The radiobiological rationale underpinning LRT encompasses direct ablation of tumor vasculature and hypoxic cores, radiation-induced bystander signaling in low-dose valleys, immunogenic cell death, and the preservation of tumor-infiltrating lymphocytes essential for abscopal responses. Emerging preclinical evidence suggests that coupling SFRT with immune checkpoint inhibitors may potentiate systemic antitumor immunity. Despite these promising signals, the clinical literature remains predominantly comprised of case reports and small retrospective series, with no completed randomized trials. Furthermore, existing reviews have been written from the perspective of well-resourced centers, leaving a significant gap for radiation oncologists practicing in low- and middle-income countries (LMICs) where bulky, advanced-stage tumors are disproportionately prevalent. This narrative review provides a comprehensive, practical clinical guide encompassing the historical evolution from GRID to LRT, the radiobiological framework, a detailed site-by-site evidence synthesis of all published clinical data, a proposed patient selection algorithm, and a novel tiered implementation framework stratified by linear accelerator (LINAC) capability\u2014from basic multileaf collimator (MLC)-based GRID through advanced volumetric modulated arc therapy (VMAT) with image guidance. We also examine the immunotherapeutic frontier and ongoing prospective trials. Our aim is to equip the practicing radiation oncologist, particularly in resource-diverse settings, with the knowledge needed to evaluate, adopt, and implement LRT for their patients with bulky, radioresistant tumors.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_599_26","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:14Z","timestamp":1786780814000},"page":"474-481","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Lattice radiotherapy for bulky tumors: A practical clinical guide from evidence synthesis to linac-based implementation in diverse resource settings"],"prefix":"10.4103","volume":"22","author":[{"given":"M. Sai","family":"Pranav","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam V.","family":"Vedagiri","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Kasi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","article-title":"The impact of tumor size on outcomes after SBRT for medically inoperable early-stage NSCLC","volume":"87","author":"Allibhai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2478\/pjmpe-2021-0015","article-title":"The role of spatially fractionated radiation therapy in the management of advanced bulky tumors","volume":"27","author":"Mahmoudi","year":"2021","journal-title":"Pol J Med Phys Eng"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0360-3016(95)00119-J","article-title":"The tumor volume and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomography","volume":"33","author":"Johnson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrclinonc.2009.188","article-title":"Stereotactic body radiation therapy: A novel treatment modality","volume":"7","author":"Lo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"R6-20260817","first-page":"209","article-title":"Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R7-20260817","first-page":"k821","article-title":"Palliative radiotherapy","volume":"360","author":"Spencer","year":"2018","journal-title":"BMJ Qual Saf"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.zemedi.2011.07.002","article-title":"[Alban K\u00f6hler (1874-1947): Inventor of grid therapy]","volume":"22","author":"Laissue","year":"2012","journal-title":"Z Med Phys"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2019.01.073","article-title":"A current review of spatial fractionation: Back to the future?","volume":"104","author":"Billena","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19900701)66:1<114::AID-CNCR2820660121>3.0.CO;2-L","article-title":"Palliative treatment of advanced cancer using multiple nonconfluent pencil beam radiation. A pilot study","volume":"66","author":"Mohiuddin","year":"1990","journal-title":"Cancer"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ijrobp.2011.01.065","article-title":"High-dose spatially fractionated grid radiation therapy (SFGRT): A comparison of treatment outcomes with cerrobend vs. MLC SFGRT","volume":"82","author":"Neuner","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20260817","article-title":"Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience. International Journal of Radiation Oncology* Biology*","author":"Wang","journal-title":"Physics"},{"key":"R13-20260817","first-page":"e9","article-title":"On modern technical approaches of three-dimensional high-dose lattice radiotherapy (LRT)","volume":"2","author":"Wu","year":"2010","journal-title":"Cureus"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1667\/RADE-20-00066.1","article-title":"The technical and clinical implementation of LATTICE radiation therapy (LRT)","volume":"194","author":"Wu","year":"2020","journal-title":"J Radiat Res"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3390\/cancers17172752","article-title":"Diagnosis-related outcome following palliative spatially fractionated radiation therapy (Lattice) of large tumors","volume":"17","author":"Studer","year":"2025","journal-title":"Cancers"},{"key":"R16-20260817","first-page":"100569","article-title":"Lattice radiation therapy in clinical practice: A systematic review","volume":"39","author":"Iori","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4274\/balkanmedj.galenos.2025.2025-2-129","article-title":"Effectiveness and Safety of Lattice Radiotherapy in Treating Large Volume Tumors: A Systematic Review and Meta-analysis Based on Single-arm Clinical Studies","volume":"42","author":"Li","year":"2025","journal-title":"Balkan Medical Journal"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1118\/1.2140116","article-title":"Feasibility of delivering grid therapy using a multileaf collimator","volume":"33","author":"Ha","year":"2006","journal-title":"Med Phys"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1667\/RADE-20-00047.1","article-title":"Photon grid radiation therapy: A physics and dosimetry white paper from the RSS Grid\/lattice, microbeam and flash radiotherapy working group","volume":"194","author":"Zhang","year":"2020","journal-title":"Radiat Res"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.meddos.2023.12.003","article-title":"Assessing dosimetric advancements in spatially fractionated radiotherapy: From grids to lattices","volume":"49","author":"At","year":"2024","journal-title":"Med Dosim"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"1512064","DOI":"10.3389\/fonc.2025.1512064","article-title":"Feasibility of optimal vertex size and spacing for lattice radiotherapy implementation using helical tomotherapy","volume":"15","author":"Seol","year":"2025","journal-title":"Front Oncol"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/153303460200100207","article-title":"The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation","volume":"1","author":"Sathishkumar","year":"2002","journal-title":"Technol Cancer Res Treat"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4161\/cbt.4.9.1915","article-title":"Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment","volume":"4","author":"Sathishkumar","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/157436207780619509","article-title":"Potential utilization of bystander\/abscopal-mediated signal transduction events in the treatment of solid tumors","volume":"2","author":"Peters","year":"2007","journal-title":"Curr Signal Transduct Ther"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2013.10.032","article-title":"High dose bystander effects in spatially fractionated radiation therapy","volume":"356","author":"Asur","year":"2015","journal-title":"Cancer Lett"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1667\/RR2780.1","article-title":"Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells","volume":"177","author":"Asur","year":"2012","journal-title":"Radiat Res"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semradonc.2019.12.006","article-title":"Novel radiation therapy paradigms and immunomodulation: Heresies and hope","volume":"30","author":"Dutt","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s11912-023-01473-7","article-title":"Immune priming with spatially fractionated radiation therapy","volume":"25","author":"Lukas","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"R30-20260817","first-page":"100691","article-title":"Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio","volume":"44","author":"Lu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: A paradigm shift","volume":"105","author":"Formenti","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1667\/RR3819.1","article-title":"In vivo effects of lattice radiation therapy on local and distant lung cancer: Potential role of immunomodulation","volume":"182","author":"Kanagavelu","year":"2014","journal-title":"Radiat Res"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3390\/cancers13030457","article-title":"Radiotherapy-immunotherapy combination: How will we bridge the gap between pre-clinical promise and effective clinical delivery?","volume":"13","author":"Romano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/radiation5010003","article-title":"Minibeam spatially-fractionated radiation therapy is superior to uniform dose radiation therapy for abscopal effect when combined with PD-L1 checkpoint inhibitor immunotherapy in a dual tumor murine mammary carcinoma model","volume":"5","author":"Rivera","year":"2025","journal-title":"Radiation"},{"key":"R35-20260817","first-page":"e4637","article-title":"Clinical outcomes of spatially fractionated GRID radiotherapy in the treatment of bulky tumors of the head and neck","volume":"11","author":"Choi","year":"2019","journal-title":"Cureus"},{"key":"R36-20260817","first-page":"100830","article-title":"Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer","volume":"48","author":"Xu","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"R37-20260817","first-page":"e4263","article-title":"Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer","volume":"11","author":"Amendola","year":"2019","journal-title":"Cureus"},{"key":"R38-20260817","first-page":"68","article-title":"Improved outcome of treating locally advanced lung cancer with the use of lattice radiotherapy (LRT): A case report","volume":"9","author":"Amendola","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.21037\/apm-22-246","article-title":"How a very large sarcomatoid lung cancer was efficiently managed with lattice radiation therapy: A case report","volume":"11","author":"Iori","year":"2022","journal-title":"Ann Palliat Med"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.ijrobp.2021.07.1253","article-title":"Lattice radiotherapy (LRT)-spatially fractionated radiotherapy (SFRT): Advanced non-small cell lung cancer (NSCLC): Early experience","volume":"111","author":"Larrea","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R41-20260817","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1667\/RADE-20-00038.1","article-title":"Spatially fractionated radiation therapy using lattice radiation in far-advanced bulky cervical cancer: A clinical and molecular imaging and outcome study","volume":"194","author":"Amendola","year":"2020","journal-title":"Radiat Res"},{"key":"R42-20260817","first-page":"e15","article-title":"Lattice radiotherapy with RapidArc for treatment of gynecological tumors: dosimetric and early clinical evaluations","volume":"2","author":"Amendola","year":"2010","journal-title":"Cureus"},{"key":"R43-20260817","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.21873\/anticanres.15968","article-title":"First-ever clinical experience with magnetic resonance-based lattice radiotherapy for treating bulky gynecological tumors","volume":"42","author":"Ferini","year":"2022","journal-title":"Anticancer Res"},{"key":"R44-20260817","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","article-title":"Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: Feasibility, safety, and promising pathologic response rates","volume":"194","author":"Snider","year":"2020","journal-title":"Radiat Res"},{"key":"R45-20260817","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/cancers17040624","article-title":"Role of spatially fractionated radiotherapy (LATTICE) treatment in inoperable bulky soft-tissue sarcomas","volume":"17","author":"Majercakova","year":"2025","journal-title":"Cancers"},{"key":"R46-20260817","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CMAR.S393934","article-title":"Neoadjuvant radiation therapy with interdigitated high-dose LRT for voluminous high-grade soft-tissue sarcoma","volume":"15","author":"Hatoum","year":"2023","journal-title":"Cancer Manag Res"},{"key":"R47-20260817","first-page":"82","article-title":"Efficacy of VMAT-lattice spatially fractionated radiation therapy (SFRT) for the treatment of large abdominal sarcoma","volume":"17","author":"Montero","year":"2023","journal-title":"Oncol Radiother"},{"key":"R48-20260817","first-page":"e85383","article-title":"Advancing intracranial tumor treatment through gyroscopic radiosurgery-based lattice therapy: Evidence from a case series study","volume":"17","author":"Yilmaz","year":"2025","journal-title":"Cureus"},{"key":"R49-20260817","first-page":"e23980","article-title":"MRI-guided online adaptive lattice stereotactic body radiotherapy in voluminous liver metastasis: Two case reports","volume":"14","author":"Dincer","year":"2022","journal-title":"Cureus"},{"key":"R50-20260817","first-page":"e89473","article-title":"Experience with the lattice technique of palliative radiotherapy for treating voluminous metastases of renal cancer","volume":"17","author":"Puente-Vallejo","year":"2025","journal-title":"Cureus"},{"key":"R51-20260817","doi-asserted-by":"crossref","first-page":"1648847","DOI":"10.3389\/fonc.2025.1648847","article-title":"Initial experience of spatially fractionated lattice radiation therapy for palliative treatment of pediatric bulky tumors","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"key":"R52-20260817","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.21873\/invivo.13719","article-title":"The promising effects of lattice radiation therapy for large, fungating, or ulcerating breast cancers: A prospective single-center study","volume":"38","author":"Ferini","year":"2024","journal-title":"In Vivo"},{"key":"R53-20260817","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/tro-24-4","article-title":"Locally advanced thymoma treated with lattice radiation therapy: A case report","volume":"8","author":"Liu","year":"2024","journal-title":"Ther Radiol Oncol"},{"key":"R54-20260817","doi-asserted-by":"crossref","first-page":"101566","DOI":"10.1016\/j.adro.2024.101566","article-title":"Time-related outcome following palliative spatially fractionated stereotactic radiation therapy (Lattice) of large tumors \u2013 A case series","volume":"9","author":"Studer","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"R55-20260817","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2021.11.023","article-title":"LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors","volume":"167","author":"Duriseti","year":"2022","journal-title":"Radiother Oncol"},{"key":"R56-20260817","doi-asserted-by":"crossref","first-page":"e13608","DOI":"10.1002\/acm2.13608","article-title":"Conebeam CT-guided 3D MLC-based spatially fractionated radiation therapy for bulky masses","volume":"23","author":"Pokhrel","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"R57-20260817","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pro6.1248","article-title":"Feasibility planning study of lattice radiotherapy for palliation in bulky tumors","volume":"8","author":"NP","year":"2024","journal-title":"Precis Radiat Oncol"},{"key":"R58-20260817","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phro.2022.04.010","article-title":"Physical aspects of a spatially fractionated radiotherapy technique for large soft tissue sarcomas","volume":"22","author":"Borzov","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R59-20260817","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.phro.2024.100549","article-title":"Script-based implementation of automatic grid placement for lattice stereotactic body radiation therapy","volume":"29","author":"Tucker","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R60-20260817","doi-asserted-by":"crossref","first-page":"e14489","DOI":"10.1002\/acm2.14489","article-title":"Semi-automated vertex placement for lattice radiotherapy and dosimetric verification using 3D polymer gel dosimetry","volume":"25","author":"Kunkyab","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"R61-20260817","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3390\/ijms26094436","article-title":"A 3D co-culture scaffold approach to assess spatially fractionated radiotherapy bystander and abscopal immune effects on clonogenic survival","volume":"26","author":"Casteloes","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R62-20260817","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13014-019-1410-1","article-title":"Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment","volume":"14","author":"Tubin","year":"2019","journal-title":"Radiation Oncology"},{"key":"R63-20260817","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13014-019-1227-y","article-title":"Novel SBRT-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY)","volume":"14","author":"Tubin","year":"2019","journal-title":"Radiat Oncol"},{"key":"R64-20260817","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijrobp.2020.01.052","article-title":"Phase I trial of MRI-guided prostate cancer lattice extreme ablative dose (lead) boost radiation therapy","volume":"107","author":"Pollack","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R65-20260817","doi-asserted-by":"crossref","first-page":"548132","DOI":"10.3389\/fonc.2020.548132","article-title":"Combined high-dose lattice radiation therapy (HDLRT) and immune checkpoint blockade for advanced bulky tumors: The concept and a case report","volume":"10","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"R66-20260817","article-title":"A Trial of Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients with Sarcoma, Thoracic, Abdominal, and Pelvic Cancers Washington University School of Medicine Division of Radiation Oncology 660 South Euclid Avenue, Campus Box 8224","author":"Duriseti"},{"key":"R67-20260817","doi-asserted-by":"crossref","first-page":"100866","DOI":"10.1016\/j.adro.2021.100866","article-title":"An international consensus on the design of prospective clinical-translational trials in spatially fractionated radiation therapy","volume":"7","author":"Mayr","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"R68-20260817","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3390\/cancers13133290","article-title":"Lattice or oxygen-guided radiotherapy: what if they converge? Possible future directions in the era of immunotherapy","volume":"13","author":"Ferini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R69-20260817","doi-asserted-by":"crossref","first-page":"100866","DOI":"10.1016\/j.adro.2021.100866","article-title":"An international consensus on the design of prospective clinical-translational trials in spatially fractionated radiation therapy","volume":"7","author":"Mayr","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"R70-20260817","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3390\/cancers13133290","article-title":"Lattice or oxygen-guided radiotherapy: What if they converge? Possible future directions in the era of immunotherapy","volume":"13","author":"Ferini","year":"2021","journal-title":"Cancers"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_599_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:20Z","timestamp":1786968080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_599_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_599_26","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}